STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS

The median survival for patients diagnosed with Glioblastoma (GBM) is only 14 months, due to recurrence, despite current treatment options of surgery, radio- and chemo- therapies. Recurrence results from the invasion of GBM cancer cells away from the initial cancerous mass and may be due to brain tu...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Bozek, Danielle, Wang, Alice, Hao, Xiaoguang, Johnston, Michael, Luchman, H Artee, Weiss, Samuel
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.943
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items